Literature DB >> 7111100

Splenectomy in agnogenic myeloid metaplasia: factors of possible prognostic significance.

S Penchas, A Steinwel, S Sukenik, J Benbassat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7111100      PMCID： PMC2426396          DOI： 10.1136/pgmj.58.678.212

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  Calculation of survival rates for cancer.

Authors:  J BERKSON; R P GAGE
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-05-24

2.  Clinical course and survival after elective splenectomy in 19 patients with primary myelofibrosis.

Authors:  H Mulder; J Steenbergen; C Haanen
Journal:  Br J Haematol       Date:  1977-03       Impact factor: 6.998

3.  Sex, splenectomy, and myeloid metaplasia.

Authors:  M N Silverstein; W H ReMine
Journal:  JAMA       Date:  1974-01-28       Impact factor: 56.272

4.  Splenectomy in myeloid metaplasia.

Authors:  M N Silverstein; W H ReMine
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

Review 5.  The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.

Authors:  H P Ward; M H Block
Journal:  Medicine (Baltimore)       Date:  1971-09       Impact factor: 1.889

6.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

7.  Malignant myelosclerosis.

Authors:  J Lubin; S Rozen; M Rywlin
Journal:  Arch Intern Med       Date:  1976-02

8.  Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases.

Authors:  J Benbassat; S Penchas; M Ligumski
Journal:  Br J Haematol       Date:  1979-06       Impact factor: 6.998

9.  Sex and splenectomy in agnogenic myeloid metaplasia.

Authors:  J Benbassat; S Penchas
Journal:  Acta Haematol       Date:  1980       Impact factor: 2.195

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.